CompaniesAccriva Diagnostics

Accriva Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

525

By Status

UNKNOWN: 3COMPLETED: 2WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT04492423
NCT03074266
NCT03615846
Hover over trial bars to see details

Recent Trials

NCT05441358Collaborator
Assessment of Platelet Function in Patients Undergoing Open Heart Surgery
N/AUnknown
75 participants
Started: Mar 23, 2022 · Completed: Jan 1, 2023
NCT03615846Lead Sponsor
Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
N/AUnknown
147 participants
Started: Feb 15, 2021 · Completed: Oct 30, 2022
NCT03930875Collaborator
Aspirin Resistance in OSA Patients
N/ACompleted
63 participants
Started: Dec 12, 2017 · Completed: Sep 7, 2018
NCT03074266Lead Sponsor
Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older
N/AUnknown
140 participants
Started: Jun 8, 2017 · Completed: Dec 31, 2018
NCT04492423Lead Sponsor
VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
N/ACompleted
100 participants
Started: Sep 6, 2016 · Completed: Mar 22, 2018
View all 6 trials →
Funding History (4)
D
Mar 11, 2015
Filing
D/A
Apr 1, 2014
Filing
D
Sep 13, 2013
Filing
D
Nov 17, 2010
Filing
Related Companies
Werfen/instrumentation Laboratory
acquired